BIT 4.76% 2.0¢ biotron limited

Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM, page-85

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 284 Posts.
    lightbulb Created with Sketch. 37
    I know right?! Especially given they explicitly referenced it March 17. Weird.

    “The results from the extended, repeat Study 2 confirm the results from Study 1, showing a
    clear clinical benefit from the treatment with BIT225.
    Supported by these results, and in consultation with USA based advisors and consultants,
    Biotron has submitted a proposal to the USA Food and Drug Administration (FDA) to conduct
    a human clinical trial to assess the efficacy of BIT225 for the treatment of COVID-19 under
    the Coronavirus Treatment Acceleration Program
    , a special emergency program for potential
    coronavirus therapies.
    Funding the clinical development of BIT225 for this indication will be sought from potential
    partners and non-equity funding sources.”


    https://hotcopper.com.au/threads/ann-bit225-effectiveness-against-covid-19-in-animals.6646745/
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
-0.001(4.76%)
Mkt cap ! $18.04M
Open High Low Value Volume
2.1¢ 2.1¢ 2.0¢ $12.00K 600.2K

Buyers (Bids)

No. Vol. Price($)
5 972631 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 199783 1
View Market Depth
Last trade - 14.33pm 01/11/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.